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Abstract 33 
Objectives: To determine the efficacy of toric intraocular lens (TIOL) implantation in cataract surgery 34 
patients with high levels of pre-operative corneal astigmatism and ocular co-morbidities in a state 35 
funded, National Health Service (NHS) hospital. 36 
Methods: Retrospective cohort study involving consecutive cases of TIOL implantation in cataract 37 
surgery with over 3.00DC of pre-operative corneal astigmatism. Subjects were implanted with the 38 
Tecnis TIOL (Abbot Medical Optics) with capsular tension ring stabilisation using the Callisto system 39 
(Carl Zeiss Meditec). Visual acuity and refraction were assessed at 4-6 weeks post-operatively. 40 
Vector analysis was used to calculate the intended refractive correction, surgically induced refractive 41 
correction (SIRC), correction ratio (CR), error of magnitude (EM) and error vector (EV). 42 
Results: 66 eyes of 47 subjects aged 73.8±11.9 were included. Eyes with ocular co-morbidities 43 
included dry age-related macular degeneration (n=13), amblyopia (n=7), high myopia (n=7), 44 
glaucoma (n=6), previous corneal transplantation (n=2), nanophthalmos (n=2) and corneal scarring 45 
(n=1). Pre-operative corneal astigmatism was 4.25±1.69DC (range 3.00-12.00), post-operative 46 
refractive astigmatism was 1.31±1.05DC (range 0.00-6.50DC) and post-operative unaided visual 47 
acuity was 0.25±0.19LogMAR. Vector analysis demonstrated an SIRC of 4.08±1.39DC, CR=1.1±0.3, 48 
EM -0.4±1.0 and EV of 1.23±0.72. 49 
Conclusions: The results demonstrate the efficacy of TIOL implantation in patients with high corneal 50 
astigmatism and provide strong evidence advocating their use in cataract surgery within a state 51 
funded hospital eye service. Refractive astigmatism was significantly lower than the pre-operative 52 
corneal astigmatism and a low error vector was achieved relative to the magnitude of correction.  53 
 54 
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Introduction 55 
Cataract surgery is the most frequently performed surgical procedure in the National Health Service 56 
(NHS), with approximately 350,000 cataract extractions performed in England and Wales per 57 
annum.1 Studies have demonstrated that around 11.% of patients have over 2.00D of corneal 58 
astigmatism2, this prevalence drops to around 2-4% when considering those with over 3.00D of 59 
corneal astigmatic error.3 Wolffsohn and colleagues demonstrated that uncorrected astigmatic error 60 
as low as 1.00D has a detrimental effect on both objective and the subjective perception of vision.4 61 
Each dioptre of refractive astigmatism reduces the chances of spectacle independence5 and 62 
increases the lifetime costs of refractive correction for an individual.6 63 
Astigmatism correction at the time of cataract surgery can be achieved through manipulation of 64 
corneal shape: An incision placed along the steep corneal meridian will have a flattening effect and 65 
the larger the incision the greater the effect7. Higher magnitudes of flattening can be achieved by 66 
applying limbal relaxing incisions8 or opposite clear corneal incisions.9 However, on-axis incisions 67 
may be difficult or impossible to achieve in certain locations. Corneal relaxing incisions can result in 68 
post-operative glare, diplopia and fluctuation of refractive error due to proximity of the incisions to 69 
the corneal centre; furthermore, the technique requires pachymetry to be performed.10 Limbal 70 
relaxing incisions entail risks such as exacerbating dry eye syndrome11 as well acting as a potential 71 
site for infectious keratits.12 All of these methods are influenced by surgical technique and are 72 
dependent on a variable corneal healing response. Consequently, it is not feasible to rely on these 73 
corneal techniques for correcting high levels of corneal astigmatism. Femtosecond laser incisions 74 
promise a more reliable technique with a more precise wound architecture, but the costs of these 75 
devices prohibit their widespread use within state funded systems such as the National Health 76 
Service (NHS) in the United Kingdom (UK).  77 
Toric Intraocular lenses (TIOLs) offer the opportunity to correct corneal astigmatism, without relying 78 
on the healing response of the cornea. Several studies have demonstrated the efficacy of TIOLS on 79 
subjects with low to moderate levels of corneal astigmatism.13 14 However few have demonstrated 80 
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their efficacy in populations with high levels of astigmatism.  Moreover, the majority of studies 81 
comprise of patient cohorts without any ocular co-morbidities and are not representative of 82 
refractive outcomes of cataract surgery in state funded healthcare. Within the UK, the National 83 
Institute for Health and Care Excellence (NICE) evidence based guidelines form the bases of 84 
treatment recommendations within the NHS. The guidelines advocate the use of on-axis incisions 85 
and limbal-relaxing incisions but not TIOLS citing a lack of evidence on the cost effectiveness of TIOL 86 
use within the UK.15 Therefore, TIOLs are not commonly available within the NHS. The purpose of 87 
this study was to assess the use of a TIOL implantation in a patients, typically presenting to the 88 
cataract service of a NHS hospital serving a large population. 89 
Methods 90 
Since November 2016, the Royal Eye Infirmary - University Hospitals Plymouth NHS trust (UHPNHST) 91 
has established a clear pathway to undertake cataract surgery with TIOL implant in patients with 92 
pre-operative keratometric cylinder of more than 3.00DC. The cut off level was based on the 93 
assumption that smaller degrees of astigmatism would be possible to manage with incisional 94 
techniques. The relatively low prevalence of corneal astigmatism greater than 3.00DC, ensured that 95 
demand for these TIOLs could be provided with a minimum impact on other clinical services. A 96 
retrospective analysis was conducted on all patients who underwent TIOL implantation between 97 
November 2016 and January 2019. This retrospective clinical audit was exempt from the UK National 98 
Research Ethics Service approval (as per NHS Health Research Authority guidance) and instead 99 
reviewed by a local institutional review board and given approval from the Clinical Effectiveness 100 
department of UHPNHST. Permission was given to access patient data, which was anonymised prior 101 
to data analysis. The study adhered to the tenets of the Declaration of Helsinki. 102 
LogMAR visual acuity was performed using the Thomson Test Chart 2000 (Thomson Software 103 
Solutions, Hatfield, Herts., UK) on patients referred to the cataract service. The pre-operative 104 
refractive error was obtained from the subjective refractive prescription by an optometrist or 105 
through objective auto-refraction. Each patient underwent corneal topography using a Pentacam 106 
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(Oculus, Wetzlar, Germany) or Topcon KR1W (Topcon, Tokyo, Japan) to rule out irregular corneal 107 
astigmatism - a contraindication to TIOL implantation. A Zeiss IOLMaster 700 (Carl Zeiss, Meditec) 108 
was used to obtain all other ocular biometry measurements according to the recommendations 109 
within the Royal College of Ophthalmologists Cataract Surgery Guidelines 2010.16 The Tecnis Toric 110 
Aspheric Intraocular lens (model ZCTXXX - Abbot Medical Optics) was used in all cases. This TIOL is a 111 
foldable hydrophobic one piece lens made of a mid-index acrylic material (refractive index of 1.47). 112 
TIOL power and orientation were chosen by inputting clinical values for axial length (AL), 113 
keratometry values (K-values), anterior chamber depth and surgeon-induced astigmatism into the 114 
manufacturers’ online calculator (TECNIS® IOL Calculator Platform, Abbot Medical Optics).  115 
On the day of surgery, all patients were consented for cataract surgery with TIOL implantation. 116 
Alignment of the TIOL was assisted with the aid of the Zeiss Callisto Eye system (Carl Zeiss, Meditec). 117 
This is a digitally assisted cataract surgery programme that utilises a preoperative image (captured 118 
with the IOLMaster 700) with relevant biometry data for review in the operating room. The ‘Z Align-119 
Toric assistant’ allows the use of reference axes from the IOLMaster and the use of target axis in the 120 
microscope eyepiece in order to provide markless alignment of TIOLS. All procedures were 121 
performed by a single surgeon (NH) using a standard surgical approach, which involved a micro-122 
coaxial phacoemulsification through a temporal 2.2 mm clear corneal incision. A manual 5.5mm 123 
capsulorhexis was performed with the aid of Callisto ‘rhexis assistant’ and a conventional ‘stop and 124 
chop” technique was used. The capsular bag was inflated with an ophthalmic viscosurgical device 125 
(Healon - Abbott Medical Optics). A polymethyl methacrylate capsular tension ring (Ophtec) was 126 
inserted to provide additional IOL rotational stability. The Tecnis TIOL was injected and aligned with 127 
the marked steep meridian, as assisted by the Callisto system (Figure 1). Healon was aspirated from 128 
inside the capsular bag, taking care to remove any remnants from behind the IOL. The IOL position 129 
was rechecked after the anterior chamber was reformed and intracameral cefuroxime 1mg/0.1ml 130 
(Aprokram – Thea Pharmaceuticals) was administered. Post-operatively all patients received 131 
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Dexamethasone 0.1%/Neomycin 0.35% eye drops (Maxitrol – Novaratis Pharmaceuticals) to the 132 
operated eye for 4 weeks. All patients attended a post-operative check on day 1 and at 4 weeks. 133 
Outcome measures such as pre- and post-operative visual acuities (unaided and best-corrected), 134 
refractions (obtained either by manifest subjective refraction or autorefraction) and all 135 
complications were recorded on Medisoft (Heidelberg Engineering GmbH). The minimum follow-up 136 
of post-implantation refractive outcomes was 4 weeks. The predicted spherical equivalent (SE) 137 
following TIOL implantation was compared with the post-operative refraction. Vector analysis was 138 
used to calculate surgically induced refractive correction (SIRC), correction ratio (CR), error 139 
magnitude (EM) and error vector (EV). 140 
Results 141 
Patient Demographics 142 
Sixty-six eyes of forty-seven participants were included in the analysis for the study. 47% of 143 
participants were male and the cohort had an average age of 73.8±12.3 years. Patients with ocular 144 
co-morbidities were included (Table 2). The magnitude of preoperative corneal keratometric 145 
cylinder ranged from 3.00 to 12.00DC and the magnitude of pre-operative refractive cylinder ranged 146 
from 1.50 to 10.25DC (Table 1; Figure 2a).  147 
Mean spherical refraction 148 
The mean post-operative mean spherical equivalent refractive error was -0.38±0.69D whilst the 149 
target spherical equivalent was -0.33±0.19D. The mean accuracy of the spherical equivalent 150 
refractive error was -0.08±0.64D with 94% within ±1.00D of the target refraction and 62% within 151 
±0.50D (Figure 2b). 152 
Visual Acuity 153 
The mean post-operative unaided vision was 0.25±0.189 LogMAR with approximately 30% of 154 
patients able to resolve 0.1LogMAR or better (Figure 2c) with two thirds of patients within European 155 
driving standards unaided (0.3 LogMAR). 156 
 157 
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Astigmatic correction  158 
The mean absolute magnitude of pre-operative corneal astigmatism and refractive cylinder was 159 
4.39±1.69D (Figure 2a) and 4.69±1.77D (Figure 2d). Following TIOL implantation the average 160 
absolute magnitude of refractive astigmatism reduced to 1.34±1.07D. 161 
The mean absolute magnitude of targeted astigmatic change was 3.74±0.90D (Figure 2e) whilst the 162 
actual achieved astigmatic change was 4.14±1.39D (Figure 2f). This demonstrated a slight 163 
overcorrection that increased as the target change increased (Figure 2g). The actual astigmatic 164 
magnitude change was within 0.50DC of the target astigmatic magnitude change in 36% of cases, 165 
within 1.00DC in 68% of cases, and within 1.50DC in 88% of cases (Figure 2g). 166 
The results of the correction ratio highlights a slight overcorrection when examining the total group 167 
(1.10±0.26). The eyes were then categorised as with-the-rule (within 20 degrees of vertical; 37 eyes), 168 
against-the-rule (within 20 degrees of horizontal; 19 eyes) or oblique (10 eyes). The correction ratio 169 
were significantly different for the different categorisations (with-the-rule 1.20±0.22; against-the-170 
rule 0.97±0.27; oblique 0.99±0.29) (F6.876, p=0.002) and analysis with the Tukey post-hoc test 171 
revealed an overcorrection of the with-the-rule eyes in comparison with both the against-the-rule 172 
(p=0.004) and the oblique eyes (p=0.45) (Figure 2j). 173 
The absolute magnitude of the difference vector (1.27±0.72D) was relatively small given the overall 174 
magnitude of astigmatic change (Figure 2i) with the refractive astigmatism angle of error greater 175 
than 15 degrees in only 8% of eyes (Figure 2j). 176 
 177 
Discussion:  178 
This is the first study to evaluate the outcomes of TIOL implantation, specifically in subjects with 179 
both high corneal astigmatism and ocular co-morbidities, as part of a defined care pathway within 180 
an NHS trust. The results highlight the effectiveness of TIOL correction within this population as 181 
demonstrated by a surprisingly accurate correction index of (1.10±0.26). In a randomised controlled 182 
trial (RCT) conducted by Holland et al.17  90% of subjects implanted with a TIOL had a residual 183 
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refractive cylinder of 1.00DC or less. In comparison, the mean residual astigmatism in our study was 184 
1.34±1.07DC. This can be attributed to the fact that a residual refractive astigmatic error was 185 
expected given that emmetropia was not the target in all cases. The expected post-operative 186 
residual astigmatism ranged from 0.01 to 6.84DC (0.65±1.09DC). Uncorrected visual acuity was also 187 
lower, which is attributed to the presence of ocular co-morbidities. As such, these findings would be 188 
representative of a typical NHS cohort; which may make our results potentially applicable to trusts 189 
all over the UK.    190 
Studies evaluating the efficacy of TIOL in high corneal astigmatism are relatively sparse and it is 191 
difficult to compare results given differences in methodologies. Alio et al.18 conducted a prospective 192 
study examining the effectiveness of TIOL in 21 eyes with corneal astigmatism greater than 2.25D. In 193 
this study a slight under correction was achieved (target astigmatic change: 4.54±2.72D; Achieved 194 
astigmatic change: 4.18±1.39) as reflected by the correction index (0.91±1.23). Both the post-195 
operative vision (0.65±0.22 decimal) and refractive astigmatic cylinder (0.45±0.63DC) were better 196 
than those in the present study. However, this discrepancy can be explained by the fact that the 197 
authors excluded co-morbidities and that the expected residual refractive cylinder was lower than in 198 
the present study. Similarly, Entabi et al.19 evaluated the use of T-flex TIOL in a prospective study on 199 
33 eyes with corneal astigmatism greater than 2.00DC. The mean preoperative refractive cylinder of 200 
2.94 ± 0.91D was lower in the Entabi study, as was the target residual astigmatism. As such, it is 201 
expected that these subjects would achieve better-unaided visual acuity and lower overall residual 202 
refractive astigmatism. However, the study did not report the astigmatic outcomes according to the 203 
standardized vector analysis first described by Alpins20 21 22, making it difficult to understand the 204 
nuances of the astigmatic correction achieved in this study. Similarly, this type of reporting is only 205 
partially utilised in the study by Visser et al.23 which examined the use of four AcrySof TIOLs in 67 206 
eyes with corneal astigmatism greater than 2.25DC (mean preoperative cylinder 4.02 ± 1.28DC). In 207 
concurrence with the present study, Visser et al. included eyes with ocular comorbidities finding 208 
comparable mean residual refractive cylinder and achieved astigmatic change 4.14±1.39DC.  209 
9 
 
Our results demonstrated a significantly greater overcorrection in eyes categorised as having with-210 
the-rule astigmatism. This can be explained by the work of Koch et al. who demonstrated that 211 
corneal power is overestimated in cases of with-the-rule astigmatism, when only the anterior 212 
surface of the cornea is assessed. They proposed that the cornea should be assessed using a method 213 
that includes posterior corneal curvature evaluation. If a device that calculates corneal astigmatism 214 
from the anterior corneal surface is used, then the results should be adjusted using a nomogram.24 215 
Residual astigmatism significantly impacts on patients’ visual acuity after cataract surgery.25 216 
Astigmatic correction during cataract surgery enables the possibility of spectacle independence at 217 
distance. For the patient, the benefits are not only economic26 but also practical. Spectacle 218 
correction of astigmatism creates a meridional magnification, which when coupled with the 219 
associated back vertex distance, produces retinal images that are both asymmetrically magnified and 220 
distorted. The images produced can decrease spatial perception27 with adaptation being particularly 221 
challenging in the elderly population28 – in whom the burden of cataract is prevalent. The correction 222 
of corneal astigmatism during cataract surgery, brings an important advantage in that no significant 223 
meridional magnification is induced due to a negligible vertex distance.29  224 
Conclusion:  225 
We believe that our results may offer evidence for this visually rehabilitating treatment to those 226 
with pre-existing compromised vision and hopefully resulting in a better quality of life. Previous 227 
studies often excluded patients with pre-existing ocular co-morbidities; leaving a paucity of evidence 228 
based management of these individuals, who constitute a considerable population undergoing 229 
cataract surgery in the UK. The cost-benefit analysis of the widespread use of these IOLs may 230 
potentially outweigh the use topography and need for IOL realignment but this requires further 231 
inquiry. In conclusion, the results demonstrate the efficacy of TIOL implantation in patients with high 232 
corneal astigmatism and provide further evidence advocating their use in cataract surgery within 233 
NHS hospital eye services.  234 
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Titles and legends to figures 
 
Figure 1. TIOL alignment on the visual axis provided by IOL master with the Callisto Eye system (Carl 
Zeiss, Meditec).  
 
Figure 2a: Pre-operative corneal keratometric astigmatism 
 
Figure 2b: Spherical equivalent refractive accuracy 
 
Figure 2c: Post-operative unaided visual acuity 
 
Figure 2d: Post-operative refractive astigmatism 
 
Figure 2e: Intended refractive correction 
 
Figure 2f: Surgically induced astigmatism vector 
 
Figure 2g: Intended refractive correction compared to surgically induced refractive correction 
 
Figure 2h: Error vector 
 
Figure 2i: Refractive astigmatism angle of error 
 
Figure 2j: Correction index 
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 Mean spherical equivalent -0.83±5.00D -13.13 to +8.50D
J0 -0.83±4.39D -8.88 to +8.32D
J45 -0.27±2.17D -4.97 to +6.89D
Pre-operative visual Acuity 0.52±0.28 LogMAR 0.18 to 1.6 LogMAR
Pr
e-
O
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ra
tiv
e 
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rn
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Absolute keratometric cylinder 
power 
4.38±1.69D 3.00 to 12.00D 
J0 -0.96±4.15 -6.89 to 11.53D 
J45 -0.17±2.06 -4.95 to 5.08D 
Table 1: Pre-operative corneal and refractive data 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Co-morbidities Number of eyes affected 
Retinal  Dry age-related macular degeneration – 13
Retinoschisis – 1 
Neuro-ophthalmology Abducens nerve palsy – 1 
Chronic external ophthalmoplegia – 1 
Corneal  Fuchs endothelial dystrophy – 2 
Corneal scarring – 1 
Previous keratoplasty – 2 
Glaucoma Chronic narrow angle – 2 
Chronic open angle – 4 
Other Amblyopia – 7 
High myopia – 7 
Nanophthalmos – 2 
Table 2: ocular co-morbidities 











